Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.050 |
None |
1.000 |
5 |
|
2007 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.050 |
None |
1.000 |
5 |
|
2007 |
2019 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.050 |
None |
1.000 |
5 |
|
2007 |
2019 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.330 |
None |
1.000 |
4 |
|
2016 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.030 |
None |
0.667 |
3 |
|
2008 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.030 |
None |
1.000 |
3 |
|
2006 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.320 |
None |
1.000 |
3 |
|
2006 |
2008 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lymphoma, Small Noncleaved-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hyperphosphatemia (disorder)
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
65
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1074
|
306
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diffuse Mixed-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Low Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Secondary malignant neoplasm of colon and/or rectum
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
397
|
68
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Lymphoma, Intermediate-Grade
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
24
|
2
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
High Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Papilledema
|
disease |
Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
35
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Medullary carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
81
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lymphoma, Diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |